Skip to content
GenoLensGenoLens

MYCN

Chr 2p24.3

MYCN proto-oncogene, bHLH transcription factor

Aliases:
bHLHe37, N-myc, MYCNOT
MANE:
ENST00000281043.4

Annotations refreshed 10 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Fetal anomalies

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Intellectual disability

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Limb disorders

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Severe microcephaly

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Skeletal dysplasia

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • VACTERL-like phenotypes

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Non-syndromic familial congenital anorectal malformations

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

+1 more panels — install the extension to see the full list inline on any page.

Disease associations (Open Targets)

  • Feingold syndrome type 1

    0.82
  • Feingold syndrome

    0.69
  • megalencephaly-polydactyly syndrome

    0.68
  • basal cell carcinoma

    0.56
  • neurodegenerative disease

    0.53
  • hereditary disease

    0.52
  • prostate carcinoma

    0.46
  • non-melanoma skin carcinoma

    0.39
  • melanoma

    0.38
  • skin basal cell carcinoma

    0.38

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

N-myc proto-oncogene protein

Positively regulates the transcription of MYCNOS in neuroblastoma cells

Curated MONDO disease pages that list MYCN among their top associated genes.

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.